Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors

DOI: 10.1080/2162402X.2017.1378842

Keywords: cytokines, solid tumors, T cells, TCR gene therapy, tumor microenvironment

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text